ÂÜÀòÂÒÂ×

Gilbert Keller is a biotechnology executive with over twenty five years of experience in biopharma, industrial biotechnology, pharmacological sciences, drug development, drug metabolism, cell biology and cancer research. From 2015 to present, they have been the Vice President Preclinical Sciences at MatriSys BioScience, where they have been developing therapeutics and skin care products at the interface of the innate immune system and the skin microbiome. From 2004 to 2015, they were the Executive Director and Senior Research Fellow at Halozyme Therapeutics, Inc. From 2001 to 2004, they were the Director of Pharmacology and Pathology at Diadexus. From 1988 to 2001, they were the Senior Scientist and Group Leader at Genentech, where they managed Ph.D. scientists and research associates involved in the discovery and development of candidate molecules, including Mabs, cytokines and growth factors.

Gilbert Keller obtained a Doctor in Science from the Medical & Science Faculties at the University of Geneva, Switzerland, specializing in Cell Biology and Neurobiology.